keyword
https://read.qxmd.com/read/38255983/cortical-and-striatal-astrocytes-of-neonatal-rats-display-distinct-molecular-and-pharmacological-characteristics-of-dopamine-uptake
#21
JOURNAL ARTICLE
Vesna Sočan, Klemen Dolinar, Mojca Kržan
Astrocytes are crucial in the regulation of neurotransmitter homeostasis, and while their involvement in the dopamine (DA) tripartite synapse is acknowledged, it necessitates a more comprehensive investigation. In the present study, experiments were conducted on primary astrocyte cultures from the striatum and cortex of neonatal rats. The pharmacological intricacies of DA uptake, including dependence on time, temperature, and concentration, were investigated using radiolabelled [3 H]-DA. The mRNA expression of transporters DAT, NET, PMAT, and OCTs was evaluated by qPCR...
January 11, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38227138/mirna-100-ameliorates-diabetes-mellitus-induced-erectile-dysfunction-by-modulating-autophagy-anti-inflammatory-and-antifibrotic-effects
#22
JOURNAL ARTICLE
Beining Li, Peng Hu, Kang Liu, Wenchao Xu, Jiaxin Wang, Qinyu Li, Bingliang Chen, Yuxuan Deng, Chenglin Han, Taotao Sun, Xinqi Liu, Mingchao Li, Tao Wang, Jihong Liu, Huang Lin, Ke Rao
BACKGROUND: Diabetes mellitus-induced erectile dysfunction (DMED) has become a common disease in adult men that can seriously reduce the quality of life of patients, and new therapies are urgently needed. miRNA-100 has many targets and can induce autophagy and reduce fibrosis by inhibiting the mTOR pathway and the TGF-β pathway. However, no research has been conducted with miR-100 in the field of DMED, and the specific mechanism of action is still unclear. OBJECTIVES: To ascertain the effects of miR-100 on corpus cavernosum tissue of DMED rats and vascular endothelial cells in a high glucose environment and to elucidate the relevant mechanisms in autophagy, fibrosis and inflammation to find a new approach for the DMED therapy...
January 16, 2024: Andrology
https://read.qxmd.com/read/38217611/terminal-care-in-parkinson-s-disease-real-life-use-of-continuous-subcutaneous-apomorphine-infusion-to-improve-patient-comfort
#23
JOURNAL ARTICLE
Matthieu Béreau, Mathilde Giffard, Anne-Laure Clairet, Guillaume Degenne, Laurent Tatu, Edward Richfield, Eloi Magnin, Marc Vérin, Manon Auffret
BACKGROUND: There are currently no recommendations on the therapeutic management of Parkinson's disease (PD) patients at the end of life. OBJECTIVE: To describe a cohort of patients with PD who benefited from continuous subcutaneous apomorphine infusion (CSAI) initiation at the end of their life as comfort care. METHODS: This real-life cohort includes 14 PD patients, who benefited from 24-h, low-dose CSAI (0.5-3 mg/h) in the context of terminal care...
January 4, 2024: Journal of Parkinson's Disease
https://read.qxmd.com/read/38217461/knockdown-of-programmed-cell-death-factor-4-restores-erectile-function-by-attenuating-apoptosis-in-rats-with-bilateral-cavernous-nerve-crush-injury
#24
JOURNAL ARTICLE
Yunlong Ge, Tian Xia, Zejia Feng, Yuhang Xi, Daoyuan Hu, Yude Hong, Bowen Tang, Jianjie Wu, Jialiang Chen, Hengjun Xiao
BACKGROUND: Apoptosis is an important pathologic mechanism of erectile dysfunction after radical prostatectomy. Studies have shown that programmed cell death factor 4 is connected to the modulation of apoptosis in many cells. However, the programmed cell death factor 4 function in the cavernous nerve injury erectile dysfunction is unclear. OBJECTIVE: This investigation aimed to explore the programmed cell death factor 4 function in erectile dysfunction in rats with bilateral cavernous nerve crush...
January 13, 2024: Andrology
https://read.qxmd.com/read/38170730/exploring-the-incidence-and-etiopathogenesis-of-pathological-yawning-as-adverse-side-effect-of-psychotropic-drugs
#25
JOURNAL ARTICLE
Anusa Arunachalam Mohandoss, Rooban Thavarajah
INTRODUCTION: Yawning is a normal, stereotyped physiological event in humans and animal kingdom. When excessive (>3 per 15 minutes), it is termed as pathological yawning (PY). PY could be due to many causes but more commonly associated with side-effect of drugs, notably involving those used in psychopharmacology. Though there are isolated case reports and case-series, there are no large-scale reports of PY. This work attempted to address this lacuna. MATERIAL AND METHODS: The current work attempted to identify characteristics of PY as collated from adverse drug effect databases of Australia (Database of Adverse Event Notifications), Canada (Canada Vigilance Adverse Reaction Online Database) and the United States of America (FDA Adverse Event Reporting System - FAERS)...
December 2023: Neuropsychopharmacologia Hungarica
https://read.qxmd.com/read/38154328/potentiometric-detection-of-apomorphine-in-human-plasma-using-a-3d-printed-sensor
#26
JOURNAL ARTICLE
Manar M Elhassan, Dalton L Glasco, Anjaiah Sheelam, Amr M Mahmoud, Maha A Hegazy, Shereen Mowaka, Jeffrey G Bell
Apomorphine is a dopamine agonist that is used for the management of Parkinson's disease and has been proven to effectively decrease the off-time duration, where the symptoms recur, in Parkinson's disease patients. This paper describes the design and fabrication of the first potentiometric sensor for the determination of apomorphine in bulk and human plasma samples. The fabrication protocol involves stereolithographic 3D printing, which is a unique tool for the rapid fabrication of low-cost sensors. The solid-contact apomorphine ion-selective electrode combines a carbon-mesh/thermoplastic composite as the ion-to-electron transducer and a 3D printed ion-selective membrane, doped with the ionophore calix[6]arene...
December 25, 2023: Biosensors & Bioelectronics
https://read.qxmd.com/read/38125760/dopamine-depletion-alters-neuroplasticity-related-signaling-in-the-rat-hippocampus
#27
JOURNAL ARTICLE
Bohye Kim, Joong-Sun Kim, BuHyun Youn, Changjong Moon
Dopamine (DA) plays a significant role in regulating hippocampal function, particularly in modulating synaptic plasticity. Despite this, a comprehensive understanding of the molecular mechanisms involved in neuroplasticity-related signaling influenced by DA remains incomplete. This study aimed to elucidate the changes in the expression of key molecules related to hippocampal neuroplasticity following DA depletion in rats. To induce DA depletion, unilateral striatal infusions of 6-hydroxydopamine (6-OHDA) were administered to adult Sprague-Dawley rats...
2023: Animal Cells and Systems
https://read.qxmd.com/read/38097220/-morphine-and-apomorphine-in-sad-cypress
#28
JOURNAL ARTICLE
Kamiyu Ogyu
Christie's Sad Cypress features an impressive trick with morphine and apomorphine. I read the book as if I were this killer, and also thought about the effects of morphine and apomorphine.
December 2023: Brain and Nerve, Shinkei Kenkyū No Shinpo
https://read.qxmd.com/read/38094651/apomorphine-at-the-end-of-life-a-role-to-play
#29
JOURNAL ARTICLE
Carolina Azoia, Catarina Borges, Ana Graça Velon, Rita Raimundo
No abstract text is available yet for this article.
December 2023: Movement Disorders Clinical Practice
https://read.qxmd.com/read/38054361/transporters-involved-in-adult-rat-cortical-astrocyte-dopamine-uptake-kinetics-expression-and-pharmacological-modulation
#30
JOURNAL ARTICLE
Vesna Sočan, Klemen Dolinar, Mojca Kržan
Astrocytes, glial cells in the central nervous system, perform a multitude of homeostatic functions and are in constant bidirectional communication with neuronal cells, a concept named the tripartite synapse; however, their role in the dopamine homeostasis remains unexplored. The aim of this study was to clarify the pharmacological and molecular characteristics of dopamine transport in cultured cortical astrocytes of adult rats. In addition, we were interested in the expression of mRNA of dopamine transporters as well as dopamine receptors D1 and D2 and in the effect of dopaminergic drugs on the expression of these transporters and receptors...
December 6, 2023: European Journal of Neuroscience
https://read.qxmd.com/read/38040406/neuroprotective-effect-of-dexpanthenol-on-rotenone-induced-parkinson-s-disease-model-in-rats
#31
JOURNAL ARTICLE
Cansu Bilister Egilmez, Burcu Azak Pazarlar, Mumin Alper Erdogan, Oytun Erbas
Parkinson's disease (PD) is the second most common and progressive neurodegenerative disease. This experimental study was designed to investigate the neuroprotective effects of dexpanthenol on antioxidant and anti-inflammatory processes in a rotenone-induced Parkinson's disease model in rats. Twenty-one male rats were randomly divided into 2 groups. The rotenone group (n = 14) was administered rotenone by intrastriatal injection, and the vehicle group (n = 7) was administered DMSO with the same application route...
November 29, 2023: Neuroscience Letters
https://read.qxmd.com/read/38025189/oral-administration-of-lactobacillus-inhibits-the-permeability-of-blood-brain-and-gut-barriers-in-a-parkinsonism-model
#32
JOURNAL ARTICLE
Angélica Y Nápoles-Medina, Blanca R Aguilar-Uscanga, Josué R Solís-Pacheco, Aldo R Tejeda-Martínez, Luis J Ramírez-Jirano, María F Urmeneta-Ortiz, Veronica Chaparro-Huerta, Mario E Flores-Soto
It has recently been shown that the administration of probiotics can modulate the microbiota-gut-brain axis and may have favorable effects in models of Parkinson's disease. In this study, we used a hemiparkinsonism model induced by the neurotoxin 6-OHDA to evaluate the efficacy of the administration of a four-week administration of a mixture containing the microorganisms Lactobacillus fermentum LH01, Lactobacillus reuteri LH03, and Lactobacillus plantarum LH05. The hemiparkinsonism model induced an increase in rotations in the apomorphine test, along with a decrease in the latency time to fall in the rotarod test on days 14 and 21 after surgery, respectively...
2023: Behavioural Neurology
https://read.qxmd.com/read/37993186/pharmacology-in-treatment-of-patients-with-disorders-of-consciousness
#33
REVIEW
Michael H Marino
Pharmacologic treatment of disorders of consciousness remains a critical but challenging task for clinicians. Amantadine has been shown to promote the rate of neurologic recovery for patients with traumatic disorders of consciousness when administered between 4 and 16 weeks, as demonstrated by a well-designed randomized control trial. While there are no large, randomized controlled trials to support the use of other dopaminergic medicines (bromocriptine, levodopa, apomorphine), there is a large body of literature implicating their role in improving alertness and responsiveness in disorders of consciousness...
February 2024: Physical Medicine and Rehabilitation Clinics of North America
https://read.qxmd.com/read/37984248/new-fraternine-analogues-evaluation-of-the-antiparkinsonian-effect-in-the-model-of-parkinson-s-disease
#34
JOURNAL ARTICLE
Andréia Biolchi Mayer, Henrique de Oliveira Amaral, Danilo Gustavo R de Oliveira, Gabriel Avohay Alves Campos, Priscilla Galante Ribeiro, Solange Cristina Rego Fernandes, Adolfo Carlos Barros de Souza, Raffael Júnio Araújo de Castro, Anamélia Lorenzetti Bocca, Márcia Renata Mortari
Venom-derived peptides are important sources for the development of new therapeutic molecules, especially due to their broad pharmacological activity. Previously, our research group identified a novel natural peptide, named fraternine, with promising effects for the treatment of Parkinson's disease. In the present paper, we synthesized three peptides bioinspired in fraternine: fra-10, fra-14, and fra-24. They were tested in the 6-OHDA-induced model of parkinsonism, quantifying motor coordination, levels of TH+ neurons in the substantia nigra pars compacta (SN), and inflammation mediators TNF-α, IL-6, and IL-1ß in the cortex...
November 13, 2023: Neuropeptides
https://read.qxmd.com/read/37980901/accessibility-of-device-aided-therapies-for-persons-with-parkinson-s-disease-in-poland
#35
JOURNAL ARTICLE
Katarzyna Smilowska, Tomasz Pietrzykowski, K Ray Chaudhuri, Bastiaan R Bloem, Daniel J van Wamelen
BACKGROUND: Access to care for people with Parkinson's disease (PD), in particular to device-aided therapies (DAT), is not equally distributed. OBJECTIVES: To analyse accessibility to DAT (deep brain stimulation; intraduodenal levodopa pump therapy; or apomorphine pump therapy) in Poland. METHODS: We analysed the distribution of DAT use in Poland by determining the number of persons with PD receiving one of the three DATs during 2015-2021...
November 20, 2023: Journal of Movement Disorders
https://read.qxmd.com/read/37980683/apomorphine-sublingual-film-compared-with-subcutaneous-apomorphine-for-off-episodes-in-parkinson-s-disease-an-open-label-randomized-crossover-study
#36
RANDOMIZED CONTROLLED TRIAL
Fabrizio Stocchi, Olivier Rascol, Werner Poewe, K Ray Chaudhuri, Jan Kassubek, Lydia Lopez Manzanares, Yi Zhang, Alyssa Bowling, Eric Pappert, Stacy Wu
BACKGROUND: Apomorphine sublingual film (SL-APO) and subcutaneous apomorphine (SC-APO) have been used for the treatment of OFF episodes in Parkinson's disease (PD). No study has prospectively compared efficacy and safety of these formulations. OBJECTIVE: To compare SL-APO with SC-APO for treatment of OFF episodes in PD. METHODS: An open-label, randomized, crossover study assessed SL-APO versus SC-APO in patients with PD and OFF episodes (N = 113)...
2023: Journal of Parkinson's Disease
https://read.qxmd.com/read/37969740/carbazole-and-tetrahydro-carboline-derivatives-as-dopamine-d-3-receptor-antagonists-with-the-multiple-antipsychotic-like-properties
#37
JOURNAL ARTICLE
Zhongtang Li, Fan Fang, Yiyan Li, Xuehui Lv, Ruqiu Zheng, Peili Jiao, Yuxi Wang, Guiwang Zhu, Zefang Jin, Xiangqing Xu, Yinli Qiu, Guisen Zhang, Zhongjun Li, Zhenming Liu, Liangren Zhang
Dopamine D3 receptor (D3 R) is implicated in multiple psychotic symptoms. Increasing the D3 R selectivity over dopamine D2 receptor (D2 R) would facilitate the antipsychotic treatments. Herein, novel carbazole and tetrahydro-carboline derivatives were reported as D3 R selective ligands. Through a structure-based virtual screen, ZLG-25 (D3 R K i  = 685 nmol/L; D2 R K i  > 10,000 nmol/L) was identified as a novel D3 R selective bitopic ligand with a carbazole scaffold. Scaffolds hopping led to the discovery of novel D3 R-selective analogs with tetrahydro- β -carboline or tetrahydro- γ -carboline core...
November 2023: Acta Pharmaceutica Sinica. B
https://read.qxmd.com/read/37954918/feasibility-of-home-dose-optimization-of-apomorphine-sublingual-film-in-parkinson-s-disease-patients-with-off-episodes-results-from-the-dose-optimization-phase-of-an-open-label-randomized-crossover-study
#38
JOURNAL ARTICLE
Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson, Stacy Wu
BACKGROUND: Dose optimization of sublingual apomorphine (SL-APO), a dopamine agonist for the treatment of OFF episodes in patients with Parkinson's disease (PD), has been performed under clinical supervision in clinical trials. SL-APO may be a candidate for home dosing optimization which would be less burdensome for patients. OBJECTIVES: To evaluate the feasibility and safety of home optimization of SL-APO in patients with PD and OFF episodes. DESIGN: A multicenter, randomized, crossover study comparing SL-APO with subcutaneous apomorphine was conducted, comprising an open-label dose-optimization phase and a treatment phase...
2023: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/37948848/minimal-adverse-events-occur-when-inducing-emesis-with-apomorphine-in-brachycephalic-mesocephalic-and-dolichocephalic-dogs
#39
JOURNAL ARTICLE
Ashlee E Harkins, Arun Tharma Iswara, Kayla A Jackson, Jolyn W L Low, Elizabeth C Napier, Mara C Hickey
OBJECTIVE: To determine risks of complications with emesis induction and whether facial conformation is associated with the frequency of complications. ANIMALS: 1,788 client-owned dogs that presented immediately or by referral from a primary care veterinarian following ingestion of toxic or foreign materials. METHODS: Patients with emesis induced with apomorphine for removal of toxic or foreign materials were retrospectively identified. Collected data included patient factors, routes of apomorphine administration, other therapies, adverse events, and patient outcomes...
November 10, 2023: Journal of the American Veterinary Medical Association
https://read.qxmd.com/read/37943007/an-experimental-study-of-consecutive-administration-of-ropinirole-and-apomorphine-for-emesis-induction-in-dogs
#40
JOURNAL ARTICLE
Lasse I Saloranta, Jouko M Levijoki, Arja M Vuorela
OBJECTIVE: To study the safety and effectiveness of consecutively administered ropinirole and apomorphine (both dopamine 2-like receptor agonists) for emesis induction in dogs. DESIGN: Prospective, crossover study design. SETTING: Institutional animal research facility. ANIMALS: Six healthy male purpose-bred Beagle dogs. INTERVENTIONS: Each dog received 4 treatments: (1) apomorphine infusion (21 μg/kg) over 30 minutes + ropinirole eye drops (3...
November 9, 2023: Journal of Veterinary Emergency and Critical Care
keyword
keyword
111293
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.